EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive Nanomedicine

Serena Marchiò

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Serena Marchiò. Beteiligte Einrichtung: Department of Oncology, University of Turin, 10060 Candiolo, Italy. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Nanomedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la Ricerca sul Cancro ETS, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles are widely explored in oncology as delivery platforms for cytotoxic drugs and molecularly defined therapeutic agents, including immunomodulators. While advances in nanomaterial engineering have enabled precise control over physicochemical properties, biological responses to nanoparticles remain difficult to predict and often diverge across experimental systems. Recent omics studies reveal that nanoparticle exposure induces coordinated cellular programs that extend beyond overt toxicity and are strongly shaped by delivery context, cellular state, and microenvironmental conditions. Importantly, these responses cannot be attributed solely to the payload, as nanocarriers themselves frequently engage stress, metabolic, and immune-related pathways, giving rise to non-additive and context-dependent effects. This Perspective proposes omics-based functional fingerprinting as a conceptual framework to interpret nanoparticle biology in cancer. Functional fingerprints are defined as integrated biological response states arising from nanocarrier–payload systems and resolving through transcriptomic, proteomic, metabolomic, and emerging single-cell or spatial approaches. By explicitly distinguishing carrier-dependent, payload-induced, and composite response programs, functional fingerprinting provides a means to reconcile heterogeneous observations and move beyond material-centered classification. Incorporating biological resolution and context awareness into nanoparticle profiling is expected to improve mechanistic interpretation, safety assessment, and the rational design of more predictive nanomedicine strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesNanomedicineHumansMultiomicsMetabolomicsAnimalsProteomicsAntineoplastic Agents

Stichwörter der Autor:innen

cancermetabolomicsnanoparticlenanotoxicologyprecision medicineproteomicssingle-cell omicsspatial omicssystems biologytranscriptomics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Oncology, University of Turin, 10060 Candiolo, Italy.
  • Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-Istituto di Ricovero e Cura a Carattere Scientifico (FPO-IRCCS), 10060 Candiolo, Italy.

Förderung

  • Fondazione AIRC per la Ricerca sul Cancro ETS
  • Italian Ministry of Health

Zitieren

APA

Marchiò, S. (2026). Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive Nanomedicine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041960

Vancouver

Marchiò S. Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive Nanomedicine. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041960

BibTeX
@article{Marchi2026,
  author = {Marchiò, Serena},
  title = {Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive Nanomedicine},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041960}
}
Kostenlos starten →